Drugs / Arctostaphylos uva-ursi
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03151603 | May 2017 → May 2019 | urinary tract infection | University Medical Center Goettingen | Completed | Mixed |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Arctostaphylos uva-ursi | “Arctostaphylos uva-ursi (UU, bearberry extract arbutin) is a potential alternative treatment.” PMID 29970072 ↗ Jul 2018 |
| Route | Oral | “Uva Ursi: 105 mg (Arctuvan®) 3x2 tablets orally from day 0 for 5 days” NCT03151603 ↗ |